EVOLVA N news, videos and press releases
For more news please use our advanced search feature.
EVOLVA N - More news...
EVOLVA N - More news...
- Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026
- Evolva publishes timeline of the Reverse Stock Split
- Evolva shareholders approve all motions proposed by the Board at today’s Annual General Meeting
- Evolva goes Responsible Care at in-cosmetics 2023
- Evolva publishes agenda for 2023 Annual General Meeting
- Evolva delivers accelerated revenue growth of 57% in 2022 and substantially improved profitability profile
- Grace Breeding and Evolva Holdings Partner to Develop Next-Generation, Sustainable Crop Yield and Resilience Solutions
- Evolva partners with Grace Breeding to replace chemical fertilizers with nature-based alternative
- Evolva delivers strong results with 57% revenue growth and increasing margins
- Evolva launches its Natural Nootkatone
- Evolva statement to SER communication
- Evolva: Update on activities to boost Resveratrol
- Evolva receives approval for Veri-teTM Resveratrol for animal health in Brazil
- Evolva receives grant from US CDC in the amount of USD 540,000
- Evolva’s NootkaSHIELDTM insect repellent approved in Hong Kong
- Evolva business update: Continued good business momentum
- Evolva with record half-yearly sales and new mid-term plan
- Evolva statement to SER communication
- Evolva successfully placed shares from authorized capital, raising CHF 6.3 million
- Evolva business update: On track to reach 2022 guidance
- Evolva signs distribution agreement for its Veri-teTM Resveratrol for dietary supplements in Brazil
- Evolva shareholders approve all proposed resolutions at the Annual General Meeting 2022
- Evolva achieves important product-related milestones with global customer, triggering revenues of more than 20% of FY21 total revenues
- Evolva's AGM postponed to May 5, 2022 / agenda remains unchanged
- Evolva's Board of Directors intends to further strengthen its expertise at upcoming AGM and proposes, among others, the following agenda items:
- Evolva grew product-related revenue by 40% in 2021
- Carsten Däweritz remains CFO of Evolva
- Evolva appoints Christian Wichert as new CEO to boost growth strategy and enter its next phase of development and commercialization
- EQS-Adhoc: Evolva secures additional financing lines to accelerate its growth
- EQS-Adhoc: Evolva announces private placement of 63.8m shares to VERAISON raising gross proceeds of CHF 7.5m and CFO departure
